Gastroenterology Research and Practice / 2017 / Article / Tab 2

Research Article

Factors Related to Significant Improvement of Estimated Glomerular Filtration Rates in Chronic Hepatitis B Patients Receiving Telbivudine Therapy

Table 2

Comparisons of the changes in the mean eGFR (CKD-EPI) of different subgroups of chronic hepatitis B patients treated with telbivudine therapy over time.

Wald chi-squaredf value

HBeAgPositive versus negative1.0410.308
Time31.2170.000
Interaction term14.3270.046
CirrhosisYes versus no0.1610.691
Time24.5770.001
Interaction term1.3470.987
Complete response at 6th monthYes versus no0.2610.607
Time34.3070.000
Interaction term7.8170.350
DecompensationYes versus no2.0110.156
Time21.6670.003
Interaction term5.3770.614
HBV DNA ≥ 7 log IU/mLYes versus no0.0010.966
Time32.7270.000
Interaction term6.4070.494
Age ≥ 50 yearsYes versus no11.7710.001
Time37.4270.000
Interaction term21.1570.004
GenotypeB versus C5.3910.020
Time19.1470.008
Interaction term11.5770.116

Analysis by generalized estimating equations. df: degree of freedom.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.